Certara Inc Share Price Today: Live Updates & Key Insights

Certara Inc share price today is $6.27, up -3.61%. The stock opened at $6.325 against the previous close of $6.38, with an intraday high of $6.39 and low of $6.085.

Certara Inc Share Price Chart

Certara Inc

us-stock
To Invest in {{usstockname}}
us-stock

Certara Inc Share Price Performance

$6.27 -0.0361(-3.61%) CERT at 23 Mar 2026 12:25 PM Health Information Services
Lowest Today 6.085
Highest Today 6.39
Today’s Open 6.325
Prev. Close 6.38
52 Week High 15.38
52 Week Low 6.04
Day’s Range: Low 6.085 High 6.39
52-Week Range: Low 6.04 High 15.38
1 day return -
1 Week return -5.54
1 month return -5.54
3 month return -32.8
6 month return -47.47
1 year return -43.06
3 year return -73.94
5 year return -79.84
10 year return -

Certara Inc Institutional Holdings

Wasatch Advisors LP 10.82

BlackRock Inc 8.74

Vanguard Group Inc 7.49

Dimensional Fund Advisors, Inc. 5.27

Deerfield Management Co 4.91

iShares Core S&P Small-Cap ETF 4.58

Teacher Retirement System Of Texas 3.52

ArrowMark Colorado Holdings, LLC (ArrowMark Partners) 3.45

Wasatch Core Growth 3.41

Geneva Capital Management 3.40

Ameriprise Financial Inc 3.12

State Street Corp 2.41

Vanguard Total Stock Mkt Idx Inv 2.39

Brown Brothers Harriman & Co 2.37

Citadel Advisors Llc 2.00

Morgan Stanley - Brokerage Accounts 1.99

Vanguard Small Cap Index 1.70

Mackenzie Investments 1.68

Millennium Management LLC 1.67

Fort Washington Investment Advisors Inc 1.43

Geode Capital Management, LLC 1.36

American Funds SMALLCAP World A 1.36

Capital World Investors 1.36

Fort Washington Small Company Equity 1.35

Canada Life US Small-Mid Cap Growth F 1.27

Vanguard Explorer Inv 1.11

Touchstone Small Company A 1.10

Wasatch Small Cap Value 1.08

Wasatch Small Cap Growth Investor 1.07

UBS Group AG 1.04

DFA US Small Cap Value I 1.03

Dixon Mitchell Investment Counsel Inc 0.97

Nationwide Geneva Small Cap Gr Instl Svc 0.96

Vanguard Small Cap Growth Index Inv 0.95

Calvert US Small-Cap SMA 0.83

Calvert US Small-Cap Strategy 0.83

Calvert Small-Cap A 0.82

Vanguard Institutional Extnd Mkt Idx Tr 0.81

DFA US Targeted Value I 0.78

State Street SPDR Port S&P 600 Sm CpETF 0.69

Certara Inc Market Status

Strong Buy: 4

Buy: 1

Hold: 6

Sell: 0

Strong Sell: 0

Certara Inc Fundamentals

Market Cap 979.53 M

PB Ratio 0.9179

PE Ratio 0.0

Enterprise Value 1092.12 M

Total Assets 1556.58 M

Volume 6490860

Certara Inc Company Financials

Annual Revenue FY24:385148000 385.1M, FY23:352960000 353.0M, FY22:335644000 335.6M, FY21:286104000 286.1M, FY20:243530000 243.5M

Annual Profit FY24:230632000 230.6M, FY23:214222000 214.2M, FY22:203067000 203.1M, FY21:174488000 174.5M, FY20:142765000 142.8M

Annual Net worth FY24:-12051000 -12.1M, FY23:-33727000 -33.7M, FY22:14731000 14.7M, FY21:-13266000 -13.3M, FY20:-49397000 -49.4M

Quarterly Revenue Q3/2025:104616000 104.6M, Q2/2025:104570000 104.6M, Q1/2025:106004000 106.0M, Q3/2024:94820000 94.8M, Q2/2024:93313000 93.3M

Quarterly Profit Q3/2025:64898000 64.9M, Q2/2025:63854000 63.9M, Q1/2025:64483000 64.5M, Q3/2024:57631000 57.6M, Q2/2024:40310000 40.3M

Quarterly Net worth Q3/2025:1525000 1.5M, Q2/2025:-1968000 -2.0M, Q1/2025:4743000 4.7M, Q3/2024:-1371000 -1.4M, Q2/2024:-12574000 -12.6M

About Certara Inc & investment objective

Company Information Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers model-informed drug development solutions; biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scientists working on pre-investigational new drug and translational stages; Simcyp Biopharmaceutics for formulation scientists; and Simcyp Secondary Intelligence that integrates toxicology with quantitative analysis of large networks of molecular and functional biological changes. It also provides Phoenix WinNonlin, a platform for non-compartmental analysis; Phoenix cloud that offers a secured and validated Certara Amazon Web Services workspace; Phoenix NLME, a population modeling and simulation software; and Pirana Modeling Workbench, which provides modelers with a structure to facilitate the iterative processes. In addition, it offers Chemaxon JChem engines, a chemical search engine; Chemaxon Compound Registration that supports a streamlined lead optimization process workflow; Chemaxon Design Hub, a design and tracking platform; Certara D360 software, a scientific informatics system; and Chemaxon Marvin, a chemical drawing tool. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange to define data standards and specifications; Metadata Repository that enables study design using controlled and standardized data; CoAuthor software, which creates and writes regulatory submissions and medical publications; and GlobalSubmit, a submissions management software. Certara Inc. was founded in 2008 and is headquartered in Radnor, Pennsylvania.

Organisation Health Information Services

Employees 1515

Industry Health Information Services

CEO Mr. Jon Resnick

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Certara Inc FAQs

What is the share price of Certara Inc today?

The current share price of Certara Inc is $6.27.

Can I buy Certara Inc shares in India?

Yes, Indian investors can buy Certara Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Certara Inc shares in India?

You can easily invest in Certara Inc shares from India by:

Can I buy fractional shares of Certara Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Certara Inc?

Certara Inc has a market cap of $979.53 M.

In which sector does Certara Inc belong?

Certara Inc operates in the Health Information Services sector.

What documents are required to invest in Certara Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Certara Inc?

The PE ratio of Certara Inc is N/A and the PB ratio is 0.92.